MedTrace Logo

Safety of Metformin in Pregnancy

NCT02793505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 950

Last updated 2016-06-08

No results posted yet for this study

Summary

This study aims to better characterize the risk linked to metformin use during pregnancy, using a prospective multicentric cohort design enabling a large sample size, in evaluating the rate of birth defects after first trimester exposure, as well as several other pregnancy related outcomes.

Conditions

  • Pregnancy
  • Pregestational Diabetes
  • Polycystic Ovary Syndrom

Interventions

DRUG

metformin

This is not an intervention but an observed exposure.

DRUG

any drug not known as a major teratogen or major fetotoxicant

This is not an intervention but an observed exposure.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-11-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793505 on ClinicalTrials.gov